Omnicell (OMCL) Cash & Equivalents (2016 - 2026)
Omnicell has reported Cash & Equivalents over the past 16 years, most recently at $196.5 million for Q4 2025.
- Quarterly Cash & Equivalents fell 40.09% to $196.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $196.5 million through Dec 2025, down 40.09% year-over-year, with the annual reading at $196.5 million for FY2025, 40.09% down from the prior year.
- Cash & Equivalents was $196.5 million for Q4 2025 at Omnicell, up from $180.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $614.2 million in Q2 2021 and troughed at $180.1 million in Q3 2025.
- The 5-year median for Cash & Equivalents is $392.9 million (2025), against an average of $394.2 million.
- Year-over-year, Cash & Equivalents soared 426.57% in 2021 and then plummeted 68.45% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $349.1 million in 2021, then fell by 5.35% to $330.4 million in 2022, then skyrocketed by 41.65% to $468.0 million in 2023, then dropped by 29.91% to $328.0 million in 2024, then crashed by 40.09% to $196.5 million in 2025.
- Per Business Quant, the three most recent readings for OMCL's Cash & Equivalents are $196.5 million (Q4 2025), $180.1 million (Q3 2025), and $399.0 million (Q2 2025).